DeepMed Research

NORTHWELL HEALTH

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Established: 1997-01-01

Employees: -

Market Cap: -

Website: https://www.northwell.edu/

Clinical Trials

Understanding Daily Fluctuations in Self-Regulation

Completed

Conditions: Self-Regulation
Impulsive Behavior

First Posted Date: 2016-12-30

Last Posted Date: 2018-01-24

Lead Sponsor: Northwell Health

Target Recruit Count: 116

Registration Number: NCT03006653

Locations: 🇺🇸
Center for Addiction Services and Personalized Interventions Research (CASPIR), Great Neck, New York, United States

Kypho-Intra Operative Radiation Therapy (IORT) for Localized Spine Metastasis, Phase I/II Study

Not Applicable

Completed

Conditions: Spinal Metastases

Interventions: Radiation: Kypho-IORT

First Posted Date: 2016-12-08

Last Posted Date: 2022-11-01

Lead Sponsor: Northwell Health

Target Recruit Count: 22

Registration Number: NCT02987153

Locations: 🇺🇸
Northwell Health, Lake Success, New York, United States

MicroRNAs as Diagnostic and Predictive Biomarkers for Acute Graft Versus Host Disease

Withdrawn

Conditions: Acute GVH Disease

Interventions: Other: Peripheral Venipuncture or Blood draw from Central Line

First Posted Date: 2016-09-28

Last Posted Date: 2017-10-11

Lead Sponsor: Northwell Health

Registration Number: NCT02917148

Locations: 🇺🇸
Monter Cancer Center, Lake Success, New York, United States

Using a Transcutaneous Electrical Auricular Stimulator to Harness the Cholinergic Anti-Inflammatory Pathway

Not Applicable

Completed

Conditions: Healthy Volunteers

Interventions: Device: Vagus Nerve Stimulation
Device: Sham Vagus Nerve Stimulation

First Posted Date: 2016-09-22

Last Posted Date: 2024-02-22

Lead Sponsor: Northwell Health

Target Recruit Count: 16

Registration Number: NCT02910973

Locations: 🇺🇸
Feinstein Institute, Manhasset, New York, United States

Transcutaneous Electric Nerve Stimulation (TENS) for the Treatment of Nocturnal Enuresis in Children

Not Applicable

Completed

Conditions: Bedwetting
Nocturnal Enuresis

Interventions: Device: transcutaneous electric nerve stimulation

First Posted Date: 2016-09-14

Last Posted Date: 2021-02-21

Lead Sponsor: Northwell Health

Target Recruit Count: 147

Registration Number: NCT02900495

Locations: 🇺🇸
Albany Medical College, Albany, New York, United States
🇺🇸
Pediatric Urology Associates, Tarrytown, New York, United States
🇺🇸
Cohen Children's Medical Center of NY, New Hyde Park, New York, United States

The Effect of Transcranial Direct Current Stimulation on Cognitive Side Effects of Electroconvulsive Therapy

Not Applicable

Completed

Conditions: Depressive Disorder

Interventions: Device: sham tDCS
Device: transcranial magnetic stimulation

First Posted Date: 2016-09-13

Last Posted Date: 2019-05-22

Lead Sponsor: Northwell Health

Target Recruit Count: 32

Registration Number: NCT02897843

Locations: 🇺🇸
The Zucker Hillside Hospital, Glen Oaks, New York, United States

Collaborative Care for Alcohol Use Disorders in the Patient-centered Medical Home

Phase 1

Completed

Conditions: Alcohol-Related Disorders
Alcohol Drinking
Alcohol Abuse
Alcoholism
Alcohol Use Disorders

Interventions: Behavioral: Motivation Enhancement Therapy
Behavioral: Modified Behavioral Self-Control Therapy
Other: Referral to specialty substance use disorder treatment
Drug: Naltrexone
Behavioral: Brief Advice

First Posted Date: 2016-08-31

Last Posted Date: 2023-10-30

Lead Sponsor: Northwell Health

Target Recruit Count: 27

Registration Number: NCT02885311

Locations: 🇺🇸
Northwell Health, Great Neck, New York, United States

Serratus Plane Block for Postoperative Pain Control

Phase 4

Terminated

Conditions: Outpatient Breast Surgery
Mastopexy
Augmentation
Revision

Interventions: Drug: Bupivicaine HCl
Drug: Normal Saline

First Posted Date: 2016-08-15

Last Posted Date: 2024-02-22

Lead Sponsor: Northwell Health

Target Recruit Count: 42

Registration Number: NCT02865928

Locations: 🇺🇸
Northwell Health System, New Hyde Park, New York, United States

Super-selective Intra-arterial Repeated Infusion of Cetuximab for the Treatment of Newly Diagnosed Glioblastoma

Phase 1

Recruiting

Conditions: Brain Cancer
Brain Tumor
Brain Neoplasm, Malignant
Glioblastoma
Brain Neoplasm
EGFR Gene Overexpression
GBM

Interventions: Drug: Intra-arterial Cetuximab
Drug: Intra-arterial Mannitol

First Posted Date: 2016-08-10

Last Posted Date: 2025-04-09

Lead Sponsor: Northwell Health

Target Recruit Count: 33

Registration Number: NCT02861898

Locations: 🇺🇸
Lenox Hill Brain Tumor Center, New York, New York, United States

MIF- Thyroxine Interactions in the Pathogenesis of Pulmonary Arterial Hypertension

Completed

Conditions: Pulmonary Hypertension
Pulmonary Arterial Hypertension
Interstitial Lung Disease

First Posted Date: 2016-08-08

Last Posted Date: 2018-01-09

Lead Sponsor: Northwell Health

Target Recruit Count: 99

Registration Number: NCT02858791

Locations: 🇺🇸
Northwell Health, New Hyde Park, New York, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy